Harvard Apparatus Regenerative Technology, Inc. Balance Sheet
HRGN|12 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
Harvard Apparatus Regenerative Technology, Inc. had $3M in total assets and $1M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -41.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.4M | $2.5M | $432.0K | - | - | - | - | $4.0M | $2.9M | $7.5M | $5.3M | $14.0M |
| Accounts Receivable | $16.0K | $0 | $4.0K | - | - | - | - | $0 | $42.0K | $21.0K | $5.0K | - |
| Inventory | $16.0K | $80.0K | $50.0K | - | - | - | - | - | $0 | $75.0K | $207.0K | $38.0K |
| Current Assets | $1.8M | $3.2M | $783.0K | $1.6M | $1.7M | $1.4M | $2.2M | $4.4M | $3.5M | $7.9M | $5.8M | $14.5M |
| PP&E (Net) | $6.0K | $11.0K | $25.0K | $110.0K | $217.0K | $394.0K | $479.0K | $632.0K | $1.1M | $1.1M | $1.4M | $575.0K |
| Total Assets | $2.7M | $4.4M | $2.6M | $1.9M | $2.1M | $2.0M | $2.6M | $5.0M | $4.6M | $9.0M | $7.2M | $15.1M |
| Current Liabilities | $1.5M | $1.0M | $968.0K | $4.8M | $756.0K | $814.0K | $662.0K | $1.6M | $2.8M | $654.0K | $710.0K | $495.0K |
| Shareholders' Equity | $1.1M | $3.2M | $1.6M | -$3.0M | $1.1M | $1.1M | $2.0M | $3.4M | $1.8M | $8.3M | $6.5M | $14.6M |